Citations

Showing 10 of 108094 citations.

In special coagulation, think horses not zebras: A clotted sample from a patient with congenital disorder of glycosylation
Saadalla, Abdulrahman , Stuart, Melissa K. , Ashrani, Aneel A. , Pruthi, Rajiv K. , Chen, Dong , Seheult, Jansen N. , Stuart, Melissa, Ashrani, Aneel, Pruthi, Rajiv K , Seheult, Jansen N , Chen, Dong , Saadalla, Abdulrahman M , Morava, Éva

Mayo Clinic

International Journal of Laboratory Hematology | August 10, 2022 | Volume: 45 | Issue: 1 | Pages: No page available

10.1111/ijlh.13944 | PMID 35946440 Get It

Gender Diversity in Primary Care Sports Medicine Leadership
Mattson, Laura M., Rosario‐Concepción, Raúl A. , Hurdle, Mark Friedrich B., Pagan‐Rosado, Robert , Clapp, Adrianna D.M. , Maynard, Jennifer R. , Pagán-Rosado, Robert D, Clapp, Adrianna D, Rosario-Concepcion, Raul A , Clapp, Adrianna

Mayo Clinic

Current Sports Medicine Reports | August 10, 2022 | Volume: 21 | Issue: 8 | Pages: 303-308

10.1249/jsr.0000000000000979 | PMID 35946849 Get It

Abstract Diversity, equity, and inclusion have been recognized as important drivers of excellence and innovation in the physician workforce. Given the historical underrepresentation of women in medicine, gender diversity is of interest. In this cross-sectional study, we sought to quantify leadership representation of female physicians in primary care sports medicine settings, including primary care sports medicine fellowship programs, select sports medicine societies, and select sports medicine-related scientific journals. Data were collected by querying the corresponding web site for each fellowship program, society, and journal and analyzed in a descriptive manner. Results showed that fewer female physicians hold primary care sports medicine leadership roles than men do. This work establishes a baseline for female representation in primary care sports medicine leadership; efforts should continue to increase the presence of women in leadership positions.
Limited clinical utility of a machine learning revision prediction model based on a national hip arthroscopy registry
Martin, R. Kyle , Wastvedt, Solvejg , Lange, Jeppe , Pareek, Ayoosh , Lund, Bent , Wolfson, Julian , Wolfson, Julian

Mayo Clinic

Knee Surgery, Sports Traumatology, Arthroscopy | August 10, 2022 | Volume: 31 | Issue: 6 | Pages: 2079-2089

10.1007/s00167-022-07054-8 | PMID 35947158 Get It

AbstractPurposeAccurate prediction of outcome following hip arthroscopy is challenging and machine learning has the potential to improve our predictive capability. The purpose of this study was to determine if machine learning analysis of the Danish Hip Arthroscopy Registry (DHAR) can develop a clinically meaningful calculator for predicting the probability of a patient undergoing subsequent revision surgery following primary hip arthroscopy.MethodsMachine learning analysis was performed on the DHAR. The primary outcome for the models was probability of revision hip arthroscopy within 1, 2, and/or 5 years after primary hip arthroscopy. Data were split randomly into training (75%) and test (25%) sets. Four models intended for these types of data were tested: Cox elastic net, random survival forest, gradient boosted regression (GBM), and super learner. These four models represent a range of approaches to statistical details like variable selection and model complexity. Model performance was assessed by calculating calibration and area under the curve (AUC). Analysis was performed using only variables available in the pre‐operative clinical setting and then repeated to compare model performance using all variables available in the registry.ResultsIn total, 5581 patients were included for analysis. Average follow‐up time or time‐to‐revision was 4.25 years (± 2.51) years and overall revision rate was 11%. All four models were generally well calibrated and demonstrated concordance in the moderate range when restricted to only pre‐operative variables (0.62–0.67), and when considering all variables available in the registry (0.63–0.66). The 95% confidence intervals for model concordance were wide for both analyses, ranging from a low of 0.53 to a high of 0.75, indicating uncertainty about the true accuracy of the models.ConclusionThe association between pre‐surgical factors and outcome following hip arthroscopy is complex. Machine learning analysis of the DHAR produced a model capable of predicting revision surgery risk following primary hip arthroscopy that demonstrated moderate accuracy but likely limited clinical usefulness. Prediction accuracy would benefit from enhanced data quality within the registry and this preliminary study holds promise for future model generation as the DHAR matures. Ongoing collection of high‐quality data by the DHAR should enable improved patient‐specific outcome prediction that is generalisable across the population.Level of evidenceLevel III.
Comparison of gastric emptying T‐half estimates using linear interpolation based on two, four, or nine data points
BouSaba, Joelle, Busciglio, Irene, Burton, Duane D. , Ryks, Michael, Sannaa, Wassel , Zheng, Ting , Camilleri, Michael , Burton, Duane

Mayo Clinic

Neurogastroenterology & Motility | August 10, 2022 | Volume: 34 | Issue: 10 | Pages: No page available

10.1111/nmo.14445 | PMID 35946059 Get It

The subtle tine: Asymptomatic Micra perforation incidentally discovered during cardiac surgery
Tan, Nicholas Y. , Madhavan, Malini , Greason, Kevin L. , Cha, Yong‐Mei

Mayo Clinic

Journal of Cardiovascular Electrophysiology | August 10, 2022 | Volume: 34 | Issue: 1 | Pages: 229-230

10.1111/jce.15653 | PMID 35946395 Get It

Abstract A 70‐year‐old woman with longstanding persistent atrial fibrillation underwent Micra leadless pacemaker implantation and atrioventricular nodal ablation. No postprocedural complications were noted. She subsequently underwent surgical mitral valve replacement 4 years later. During the surgery, Micra tine perforation of the right ventricular free wall was seen. No device revision was performed due to her asymptomatic status and stable pacemaker position/function. Pericardial effusion is a known complication of Micra implantation. The incidence of tine perforation is unknown as many patients may be asymptomatic. The clinical consequences regarding adverse events, device functionality, and explantation/extraction risk profile remain to be determined.
Current understanding of AD pathophysiology and impact of amyloid beta–targeted treatments on biomarkers and clinical endpoints
Petersen, Ronald C. , Graf, Ana, Carrillo, María C. , Weber, Christopher J.

Mayo Clinic

Alzheimer's & Dementia | August 10, 2022 | Volume: 18 | Issue: 8 | Pages: 1586-1586

10.1002/alz.12769 | PMID 35946224 Get It

Recent Advances in Understanding of Cardiovascular Diseases in Patients with Chronic Kidney Disease
Krisanapan, Pajaree , Pattharanitima, Pattharawin , Cheungpasitporn, Wisit , Cheungpasitporn, Wisit , Pattharanitima, Pattharawin , Krisanapan, Pajaree , Thongprayoon, Charat

Mayo Clinic

Journal of Clinical Medicine | August 10, 2022 | Volume: 11 | Issue: 16 | Pages: 4653

10.3390/jcm11164653 | PMID 36012887 Get It

Chronic kidney disease (CKD) is a major public health problem, affecting between 8% and 16% of the population worldwide [...]
A Survey on the Management of Thyroid Eye Disease Among American and European Thyroid Association Members
Brito, Juan P. , Nagy, Endre V. , Ospina, Naykky Singh , Zˇarković, Milosˇ , Dosiou, Chrysoula , Fichter, N., Lucarelli, Mark J., Hegedüs, László , Ospina, Naykky Singh , Singh Ospina, Naykky , Brito, Juan P , Dosiou, Chrysoula

Mayo Clinic

Thyroid® | August 10, 2022 | Volume: 32 | Issue: 12 | Pages: 1535-1546

10.1089/thy.2022.0172 | PMID 35946071 Get It

Background: The thyroid eye disease (TED) treatment landscape is rapidly evolving. How new treatment options have impacted practice is unknown. Methods: We conducted a cross-sectional electronic survey of American and European Thyroid Association members between June 2 and June 30, 2021. The survey included TED questions about resources for its management, index cases for different severities and presentations of TED, barriers for the management of TED, and participants' concerns about TED. We classified respondents into three geographic categories: North America, Europe, or other regions. Results: Two hundred fifty-two eligible participants started the survey (15% response rate), and 227 completed it. Participants were mostly men (50.2%, 114/227), white (79.7%, 181/227), endocrinologists with a thyroid focus (66.1%, 150/227), practicing in a tertiary academic center (46.7%, 106/227), caring for 10 or more TED patients over the last 12 months (40.5%, 92/227), and reported not having a multidisciplinary TED clinic in their institution (52.8%, 120/227). The majority reported that new TED cases per annum have not changed in the past 10 years (47.5%, 108/227), and that TED patients are found in practice during the management of hyperthyroidism (41.8%, 95/227). For mild active TED, participants from Europe reported a higher use of selenium (73%[96/132] vs. 32%[20/62] of respondents from North America and 24%[8/33] of respondents from other regions). For moderate-to-severe active TED, there was a modest preference for teprotumumab as first-line therapy (37%, 23/62) among North American participants and intravenous (IV) steroids (73%[96/132], and 42%[14/33]) for participants from Europe and other regions, respectively. These treatment preferences did not change in patients with moderate-to-severe active TED with poorly controlled diabetes. In contrast, participants from the three geographic categories preferred IV steroids for optic neuropathy and women planning pregnancy. The three top “very important” concerns about TED management according to participants were: the cost of TED treatment (31.3%, 71/227), lack of effective TED treatments (19.8%, 45/227), and difficulty in predicting whether TED will develop (18.9%, 43/227). Conclusions: There is a marked geographic practice variation in the management of TED. Clinicians' concerns about TED management demand ongoing research on more effective treatment, TED predictive tools, and policy changes to improve the affordability of new TED therapies.
Veränderung des Blickmusters in Abhängigkeit des Stadiums der Brustrekonstruktion mittels DIEP Lappenplastik – erste Daten einer Eye-Tracking-Analyse
Kantelhardt, Chiara, Frank, Konstantin , Kohler, Lukas , Alfertshofer, Michael , Hagen, Christine, Walbrun, Alina, Karcz, Konrad , Giunta, Riccardo E. , Möllhoff, Nicholas, Alfertshofer, Michael , Cotofana, Sebastian , Hagen, Christine Sophie

Mayo Clinic

Handchirurgie · Mikrochirurgie · Plastische Chirurgie | August 9, 2022 | Volume: 54 | Issue: 04 | Pages: 356-362

10.1055/a-1794-5951 | PMID 35944538 Get It

Zusammenfassung Hintergrund Die Brustrekonstruktion mittels autologem Gewebe ist fester Bestandteil eines ganzheitlichen Therapiekonzeptes bei Patientinnen mit Mammakarzinom. Während zahlreiche Studien den körperlichen und psychischen Gesundheitszustand von Patientinnen mit Brustkrebs nach Mastektomie und konsekutiver Brustrekonstruktion untersuchen, mangelt es an objektiven Daten zur Beurteilung des Einflusses von Ablatio und Brustrekonstruktion auf die Wahrnehmung von externen Beobachtern. Diese Studie untersucht die Blickmuster bei Betrachtung einer Brust in verschiedenen Stadien der Brustrekonstruktion mittels DIEP Lappenplastik. Material und Methoden Mittels Eye-Tracking-Technologie wurden die Augenbewegungen von 58 Studienteilnehmer*in- nen beim Betrachten von 2D-Fotografien einer Patientin in den verschiedenen Stadien der Brustrekonstruktion (1. Ablatio, 2. Aufbau mittels DIEP Lappenplastik, 3. MAK Rekonstruktion) analysiert. Die Zeit bis zur ersten Fixierung und die Dauer der Fixierung wurde in jedem Bild für die rechte und linke Brust aufgezeichnet. Ergebnisse Die Dauer der kompletten Fixierung der operierten Brust zeigte über die verschiedenen Stadien der Brustrekonstruktion insgesamt eine signifikante Abnahme mit p<0,001. Gleichzeitig zeigte sich keine statistisch signifikante Veränderung der Blickdauer auf der nicht-operierten Gegen- seite mit p=0,174. Die Zeit bis zur ersten Blickfixierung der betroffenen Brust zeigte eine signifikante Zunahme über die verschiedenen Rekonstruktionsschritte, mit p<0,001. Bei der Gegenseite zeigte sich kein statistisch signifikanter Unterschied in der Zeit bis zur ersten Fixierung, mit p=0,344. Schlussfolgerung Die Ablatio mammae und die einzelnen Schritte der Brustrekonstruktion verändern die äußerliche Wahrnehmung von Patientinnen. Im Laufe der einzelnen re- konstruktiven Teilschritte kommt es zu einer zunehmenden Aufhebung der Blickdeviation in Richtung erkrankte Brust.
Transoral Robotic Surgery for Recurrent Tumors of the Upper Aerodigestive Tract (RECUT): An International Cohort Study
Hardman, John , Holsinger, F. Christopher , Brady, Grainne , Beharry, Avinash , Bonifer, Alec , D’Andréa, Grégoire , Dabas, Surender, Almeida, John R. de , Duvvuri, Umamaheswar , Floros, Peter , Ghanem, Tamer , Hamilton, David W. , Larsen, Mikkel Hjordt Holm , Magnuson, J. Scott , Miles, Brett A., Moore, Eric J. , Pantvaidya, Gouri , Rubek, Niclas , Simon, Christian , Abel, Kathryn M. Van , Poorten, Vincent Vander , Walgama, Evan , Greenlay, Emily, Potts, Laura, Balaji, Arun, Starmer, Heather M. , Stephen, S. , Roe, Justin , Harrington, Kevin J. , Paleri, Vinidh , Hardman, John C , Holsinger, F Chris , Brady, Grainne C , Bonifer, Alec T , de Almeida, John R , Ghanem, Tamer A , Gorphe, Philippe , Gross, Neil D , Hamilton, David , Kurukulasuriya, Chareeni , Larsen, Mikkel Hjordt Holm , Lin, Daniel J , Magnuson, J Scott , Meulemans, Jeroen , Miles, Brett A , Moore, Eric J , Pantvaidya, Gouri , Roof, Scott , Rubek, Niclas , Subash, Anand , Topf, Michael C , Van Abel, Kathryn M , Vander Poorten, Vincent , Walgama, Evan S , Greenlay, Emily , Potts, Laura , Balaji, Arun , Roe, Justin , Harrington, Kevin , Paleri, Vinidh , Topf, Michael C.

Mayo Clinic

JNCI: Journal of the National Cancer Institute | August 9, 2022 | Volume: 114 | Issue: 10 | Pages: 1400-1409

10.1093/jnci/djac130 | PMID 35944904 Get It

Abstract Background Transoral robotic surgery (TORS) is an emerging minimally invasive surgical treatment for residual, recurrent, and new primary head and neck cancers in previously irradiated fields, with limited evidence for its oncological effectiveness. Methods A retrospective observational cohort study of consecutive cases performed in 16 high-volume international centers before August 2018 was conducted (registered at clinicaltrials.gov [NCT04673929] as the RECUT study). Overall survival (OS), disease-free survival, disease-specific survivals (DSS), and local control (LC) were calculated using Kaplan-Meier estimates, with subgroups compared using log-rank tests and Cox proportional hazards modeling for multivariable analysis. Maximally selected rank statistics determined the cut point for closest surgical resection margin based on LC. Results Data for 278 eligible patients were analyzed, with median follow-up of 38.5 months. Two-year and 5-year outcomes were 69.0% and 62.2% for LC, 71.8% and 49.8% for OS, 47.2% and 35.7% for disease-free survival, and 78.7% and 59.1% for disease-specific survivals. The most discriminating margin cut point was 1.0 mm; the 2-year LC was 80.9% above and 54.2% below or equal to 1.0 mm. Increasing age, current smoking, primary tumor classification, and narrow surgical margins (≤1.0 mm) were statistically significantly associated with lower OS. Hemorrhage with return to theater was seen in 8.1% (n = 22 of 272), and 30-day mortality was 1.8% (n = 5 of 272). At 1 year, 10.8% (n = 21 of 195) used tracheostomies, 33.8% (n = 66 of 195) used gastrostomies, and 66.3% (n = 53 of 80) had maintained or improved normalcy of diet scores. Conclusions Data from international centers show TORS to treat head and neck cancers in previously irradiated fields yields favorable outcomes for LC and survival. Where feasible, TORS should be considered the preferred surgical treatment in the salvage setting.